260. Sitosterolemia Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 13 / Drugs : 7 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathway : 1
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Combination OF fish OIL and colesevelam
University of Manitoba
2018 - NCT01948648 Canada
Ezetimibe
National Heart, Lung, and Blood Institute (NHLBI)
2004 Phase 3 NCT00099996 United States
Organon and Co
2007 - NCT00705211 -
2007 - NCT00704444 -
2002 Phase 3 NCT00092833 United States
University of Manitoba
2012 - NCT01584206 Canada
Ezetrol
MSD SHARP & DOHME GMBH
2004 - EUCTR2004-001580-22-DE Germany;United Kingdom
Merck Sharp & Dohme Ltd
2004 - EUCTR2004-001580-22-GB Germany;United Kingdom
High/LOW sitosterol
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
2007 - NCT00531128 United States
MK-0653
MSD SHARP & DOHME GMBH
2004 - EUCTR2004-001580-22-DE Germany;United Kingdom
Merck Sharp & Dohme Ltd
2004 - EUCTR2004-001580-22-GB Germany;United Kingdom
MK0653, ezetimibe
Organon and Co
2004 Phase 3 NCT00092898 United States
2001 Phase 3 NCT00092820 -
2001 Phase 3 NCT00092807 United States
SCH-58235
National Heart, Lung, and Blood Institute (NHLBI)
2004 Phase 3 NCT00099996 United States
2001 Phase 2 NCT00045812 United States
University of Manitoba
2018 - NCT01948648 Canada
Ezetimibe
National Heart, Lung, and Blood Institute (NHLBI)
2004 Phase 3 NCT00099996 United States
Organon and Co
2007 - NCT00705211 -
2007 - NCT00704444 -
2002 Phase 3 NCT00092833 United States
University of Manitoba
2012 - NCT01584206 Canada
Ezetrol
MSD SHARP & DOHME GMBH
2004 - EUCTR2004-001580-22-DE Germany;United Kingdom
Merck Sharp & Dohme Ltd
2004 - EUCTR2004-001580-22-GB Germany;United Kingdom
High/LOW sitosterol
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
2007 - NCT00531128 United States
MK-0653
MSD SHARP & DOHME GMBH
2004 - EUCTR2004-001580-22-DE Germany;United Kingdom
Merck Sharp & Dohme Ltd
2004 - EUCTR2004-001580-22-GB Germany;United Kingdom
MK0653, ezetimibe
Organon and Co
2004 Phase 3 NCT00092898 United States
2001 Phase 3 NCT00092820 -
2001 Phase 3 NCT00092807 United States
SCH-58235
National Heart, Lung, and Blood Institute (NHLBI)
2004 Phase 3 NCT00099996 United States
2001 Phase 2 NCT00045812 United States